"Tentatively Positive" into Eliem's (ELYM) ETX-810 Data - Stifel Reiterates Stock at Buy Jul 22, 2022 07:19AM
UPDATE: Eliem Therapeutics (ELYM) Reiterated at Buy by Stifel Despite ETX-810 Failure, "Still Like LSR Set-Up, But Stock Now Materially Riskier" Apr 25, 2022 07:38AM
Stifel Reiterates Buy Rating on Eliem Therapeutics (ELYM), Sees Positive Risk/Reward Ahead of Upcoming ETX-810 Readouts Apr 12, 2022 05:12PM
Stifel Reiterates Buy Rating on Eliem Therapeutics Inc. (ELYM), Analyst Remains Optimistic on Prospects of ETX-810 Feb 16, 2022 05:12PM